STENOCARE signs agreement with new prominent supplier, PANAXIA and announces imminent product approval application filing. 28-02-2020. Notice to Extraordinary General Meeting in STENOCARE A/S. 27-02-2020. STENOCARE: New video regarding the profitable Year-End Report 2019 and the road ahead.

STENOCARE A/S NASDAQ FIRST NORTH GROWTH MARKET, DENMARK TICKER: STENO STENOCARE A/S ("STENOCARE") and Emerald Health Therapeutics Inc ("Emerald") hereby announces that the first shipment and delivery of medical cannabis oil has been completed on December 23, 2020 to Sweden.

Vancouver, British Columbia--(Newsfile Corp. - September 10, 2020) - Emerald Health Therapeutics, Inc. (TSXV: EMH) (OTCQX: EMHTF) ("Emerald") and STENOCARE A/S today announced that they have received special approval from the Swedish Medicines Agency to provide medical cannabis oil to Swedish patients who have applied via their doctor to use such products for treatment purposes. At STENOCARE we welcome the good news regarding reclassification of medical cannabis is perceived as a supporting factor for future growth for the industry, and also great news for patients that would like to have access to treatment with medical cannabis". Stenocare är en dansk leverantör inom medicinsk cannabis.

The new edition of The European Cannabis Report 5th Edition was published February 2020, and in the section “Companies to Watch” the Report profile STENOCARE as one of few medical cannabis leaders in Europe: STENOCARE 2.0-strategin bygger tillgångar inom tre kategorier, som kompletterar varandra och är viktiga för företagets framgång: Kommersiella tillgångar: Att ha receptbaserade medicinska cannabisprodukter godkända enligt det mycket strikta danska regelverket gör det möjligt för bolaget att nyttja denna tillgång på både den danska marknaden och framtida marknader. STENOCARE A/S is founded in 2017 to work with the Danish legalization program for medical cannabis to give better quality of life for patients. The company import’s and sell finished products for the Danish market via distributors. Stenocare has subsequently terminated its collaboration with Canntrust and chosen not to import more products from the company.

Stenocare avnoterar sig från Spotlight och flyttar till First North Köpenhamn. https://ipohub.io/companies/stenocare-as/news/decision-to-list-and-publication-of-

STENOCARE A/S : News, information and stories for STENOCARE A/S | Other OTC: STEOF | Other OTC 2021-04-07 STENOCARE har valgt at stoppe med import og distribution af vores tre Medicinsk cannabis olie-produkter ”STENOCARE DROPS”. Årsagen er, at leverandøren af produkterne har en igangværende sag med de Canadiske myndigheder, fordi de har anvendt dyrkningsrum til produktionen, som ikke havde fået endelig godkendelse til at blive anvendt. Stenocare has a market capitalisation of kr.191m and burnt through kr.22m last year, which is 11% of the company's market value. Given that situation, it's fair to say the company wouldn't have much trouble raising more cash for growth, but shareholders would be somewhat diluted.

May 9, 2020 An angel investment for the young startup came "out of the blue" from former Kroger exec Dave Dillon, said Lee Zuvanich, Stenovate COO.

STENOCARE. 914 likes.

Early this morning, STENOCARE received new and more detailed information from CannTrust which indicates that most, yet not all, of the CannTrust products that STENOCARE has in inventory and that STENOCARE has supplied to the Danish market since June 10, 2019 Find the latest STENOCARE A/S (STENO.CO) stock quote, history, news and other vital information to help you with your stock trading and investing. Share Price & News. How has Stenocare's share price performed over time and what events caused price changes? Latest Share Price and Events. Stable Share Price: STENO is more volatile than 75% of Danish stocks over the past 3 months, typically moving +/- 8% a week. Teckningstiden i STENOCARE A/S nyemission inleds idag mån, sep 24, 2018 08:45 CET. Idag, den 24 september 2018, inleds teckningstiden i STENOCARE A/S ("STENOCARE" eller "Bolaget") nyemission inför planerad notering på Spotlight Stock Market ("Spotlight").
Hur manga partier finns det

STENOCARE A/S was founded in 2017 with the purpose of being an active participant in the Danish medical cannabis pilot program. The company was first to receive the Danish Medicines Agency's permission to import, distribute as well as cultivate and produce medical cannabis.

Copy link to Tweet; Embed Tweet. Stenocare Snart dags för lyft.
Omma pungkulor

Please watch: "Hele min portefølje: Ny Portefølje- og investeringsplatform" https://www.youtube.com/watch?v=RnkmS0tE4kw --~--Investering i hash Stenocare I

914 likes. STENOCARE A/S blev stiftet i 2017 med det ene formål at være en aktiv deltager i den danske forsøgsordning med medicinsk cannabis.

Aktiekurser stenocare. STENOCARE - Cision News — Det medicinska cannabisbolaget Stenocare aktie tokrusade nÃ¤r aktien

Share Price & News. How has Stenocare's share price performed over time and what events caused price changes? Latest Share Price and Events. Stable Share Price: STENO is more volatile than 75% of Danish stocks over the past 3 months, typically moving +/- 8% a week. Teckningstiden i STENOCARE A/S nyemission inleds idag mån, sep 24, 2018 08:45 CET. Idag, den 24 september 2018, inleds teckningstiden i STENOCARE A/S ("STENOCARE" eller "Bolaget") nyemission inför planerad notering på Spotlight Stock Market ("Spotlight"). Find the latest news headlines from Stenocare AS (STEOF) at Nasdaq.com.

Corp Ignite International Brands Ltd Stenocare Aphria GW Det var ett helt Finansiell sammanfattning; Ignite binternational brands ltd news. Aktiekurser stenocare. STENOCARE - Cision News — Det medicinska cannabisbolaget Stenocare aktie tokrusade nÃ¤r aktien Turbulenta år för Stenocare men intresset från såväl läkare som patienter är högt. Läs artikeln gratis genom att logga in eller skapa konto. I dag lanserades det danska cannabisbolaget Stenocare på aktiemarknadsplatsen Spotlight – och intresset har under morgonen varit enormt. Stenocare.com STENOCARE A/S is a Licensed Producer of prescription-based medical cannabis under the Medical Cannabis Pilot Programme in Denmark.